Downloading...
Download

Liftoff

My Outlook for Eth. 1/13/2022So lads and ladies. Its been a while. Your boys back. After following the crypto market as well as the US and UK economy and key facts figures and events may that be worldwide or domestic. Things are looking better and better for cryptocurrencies fundamentally along with the technical. We are starting to see mass adoption not just in the form of its use as a layer 1 whether that be P2P transactions or how its ERC20 token has revolutionised the world of digital art and entertainment. Ethereums Dapps are revolutionising the space especially now with Wormhole. We have been trending down from its previous ATH at 4.8K. We have reached a significant demand zone based on Tesla and other big companies and funds buy zone during the 2020-21 bull run. These companies are very unlikely to sell but more likely to buy at this zone. I have been playing this zone and we have now seen an impulsive move up post CPI figures release. Inflation rate is growing rapidly. A couple 1:4 setups low risk small positions just trying to gauge the market.
BITSTAMP:ETHUSDLong
by Kmulla369
BTCUSD :: Has liftoff commenced? 20% uptrend to test resistance?The four hour chart has started a strong uptrend solidly closing a bar above the 50/200 4H EMA crossover. Could this spell the end of the sideways trend and signal BTC heading for channel resistance test around $70k? I think it very well may, but I'm still holding other coins that I think will rise along with it and with a larger percentage. I anticipate pulling some profit as it nears the trend line from my other holdings then apeing on the correction. The big test will be if it can close today & tomorrow's candle above the 50D MA and to the right of the presently being tested 45 degree daily downtrend line, imo.
COINBASE:BTCUSDLong
by lazytrade
MLNT Pullback and Continuation Possible uptrend continuation into March 12th earnings. *320% expected quarterly revenue. *50% decrease in short interest. *NDA filing on phase 3 data for Baxdela in 1H 2019. *19% volume increase in past 4 days. Entry Points - 1.32 - 1.45 Price Targets - 1.72---2.00---2.26---2.43 Stop-Loss - 1.25 Melinta Therapeutics Company Profile Melinta Therapeutics, Inc, a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers Baxdela, an antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Vabomere, a carbapenem used in treatment of gram-negative infections; Orbactiv, an antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; and Minocin, a IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens, as well as Solithromycin, a macrolide antibiotic for the treatment of CABP.
MLong
by Crispier-Bacon
Melinta Therapeutics - MNLT Continued BreakoutPossible Continuation into March 12th earnings. *Expected quarterly revenues up 320%. *Short interest has decreased 50.2% since mid December. *Average daily volume is up 19% over the past 4 days. *NDA filing for Baxdela Phase 3 data 1H 2019 Entry Points: 1.32-1.45 Price Targets: 1.74---2.00---2.26---2.43 Tight Stop-Loss at 1.25 Company Info Melinta Therapeutics, Inc, a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers Baxdela, an antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Vabomere, a carbapenem used in treatment of gram-negative infections; Orbactiv, an antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; and Minocin, a IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens, as well as Solithromycin, a macrolide antibiotic for the treatment of CABP.
MLong
by Crispier-Bacon
15 Month Triangle about to break on LTCCNYIf/when LTCCNY breaks up out of this triangle at about 34 cny, I hope you will be long! (I've been long for a while) I have a target of ~74 cny, stoploss. Corresponds very closely to 1-1 triangle breakout, also old S/R level, and finally 1.618 fib retracement from last July's peak. It's looking very promising with daily RSI crossing into overbought territory which usually happens at the beginning of the really big LTCCNY moves.
LLong
by cryptographic1
20